Finding 529535 (2022-006)

Significant Deficiency
Requirement
AB
Questioned Costs
-
Year
2022
Accepted
2025-03-24
Audit: 347522
Organization: National Indian Health Board (DC)
Auditor: Sikich CPA LLC

AI Summary

  • Core Issue: Missing or unsigned salary documentation for four employees during payroll testing.
  • Impacted Requirements: Failure to maintain signed offer letters or salary change forms violates compliance with Uniform Guidance.
  • Recommended Follow-up: Ensure all salary documentation is properly signed and retained for all active employees to strengthen controls and compliance.

Finding Text

2022-006 Missing or unsigned salary documentation 93.341 Analyses, Research and Studies to Address the Impact of CMS Programs on American Indian/Alaska Native (AI/AN) Beneficiaries and the Health Care System Serving these Beneficiaries 93.421 Strengthening Public Health Systems and Services Audit Results: Criteria:Signed offer letters or salary change forms should be maintained for all active employes as evidence of approval of salary rates. Condition:During our testing of payroll, we noted that offer letters or salary change forms were not signed or could not be located for four of the employees tested. Effect:As a result, the Organization did not maintain the proper signed documentation for employee salaries. Cause:This is due to lack of controls over document retention resulting from employee turnover. Recommendation: Auditors recommend that offer letters and salary change forms are maintained for all active employees as documentary evidence that salary rates have been approved. It is critical that salary rates and changes be approved in order to be in compliance with Uniform Guidance requirements. Views of Responsible Officials and Planned Corrective Actions: Management agrees with this Single Audit Finding and response is included in the Corrective Action Plan.

Categories

No categories assigned yet.

Other Findings in this Audit

  • 529528 2022-005
    Material Weakness Repeat
  • 529529 2022-006
    Significant Deficiency
  • 529530 2022-007
    Material Weakness
  • 529531 2022-005
    Material Weakness Repeat
  • 529532 2022-006
    Significant Deficiency
  • 529533 2022-007
    Material Weakness
  • 529534 2022-005
    Material Weakness Repeat
  • 529536 2022-007
    Material Weakness
  • 529537 2022-005
    Material Weakness Repeat
  • 529538 2022-006
    Significant Deficiency
  • 529539 2022-007
    Material Weakness
  • 529540 2022-005
    Material Weakness Repeat
  • 529541 2022-006
    Significant Deficiency
  • 529542 2022-007
    Material Weakness
  • 529543 2022-005
    Material Weakness Repeat
  • 529544 2022-006
    Significant Deficiency
  • 529545 2022-007
    Material Weakness
  • 529546 2022-005
    Material Weakness Repeat
  • 529547 2022-006
    Significant Deficiency
  • 529548 2022-007
    Material Weakness
  • 529549 2022-005
    Material Weakness Repeat
  • 529550 2022-006
    Significant Deficiency
  • 529551 2022-007
    Material Weakness
  • 529552 2022-005
    Material Weakness Repeat
  • 529553 2022-006
    Significant Deficiency
  • 529554 2022-007
    Material Weakness
  • 529555 2022-004
    Material Weakness Repeat
  • 529556 2022-005
    Material Weakness Repeat
  • 529557 2022-006
    Significant Deficiency
  • 1105970 2022-005
    Material Weakness Repeat
  • 1105971 2022-006
    Significant Deficiency
  • 1105972 2022-007
    Material Weakness
  • 1105973 2022-005
    Material Weakness Repeat
  • 1105974 2022-006
    Significant Deficiency
  • 1105975 2022-007
    Material Weakness
  • 1105976 2022-005
    Material Weakness Repeat
  • 1105977 2022-006
    Significant Deficiency
  • 1105978 2022-007
    Material Weakness
  • 1105979 2022-005
    Material Weakness Repeat
  • 1105980 2022-006
    Significant Deficiency
  • 1105981 2022-007
    Material Weakness
  • 1105982 2022-005
    Material Weakness Repeat
  • 1105983 2022-006
    Significant Deficiency
  • 1105984 2022-007
    Material Weakness
  • 1105985 2022-005
    Material Weakness Repeat
  • 1105986 2022-006
    Significant Deficiency
  • 1105987 2022-007
    Material Weakness
  • 1105988 2022-005
    Material Weakness Repeat
  • 1105989 2022-006
    Significant Deficiency
  • 1105990 2022-007
    Material Weakness
  • 1105991 2022-005
    Material Weakness Repeat
  • 1105992 2022-006
    Significant Deficiency
  • 1105993 2022-007
    Material Weakness
  • 1105994 2022-005
    Material Weakness Repeat
  • 1105995 2022-006
    Significant Deficiency
  • 1105996 2022-007
    Material Weakness
  • 1105997 2022-004
    Material Weakness Repeat
  • 1105998 2022-005
    Material Weakness Repeat
  • 1105999 2022-006
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.341 Analyses, Research and Studies to Address the Impact of Cmsõ Programs on American Indian/alaska Native (ai/an) Beneficiaries and the Health Care System Serving These Beneficiaries $835,945
93.011 National Organizations of State and Local Officials $437,983
93.421 Covid-19 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $253,538
93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $169,942
93.421 Strengthening Public Health Systems and Services Through National Partnerships to Improve and Protect the Nation’s Health $107,186
93.933 Demonstration Projects for Indian Health $127